Prograf is an immunosuppressive drug primarily used to prevent organ rejection after liver, kidney, or heart transplants. It contains tacrolimus, which inhibits the activity of immune cells responsible for attacking the transplanted organ, reducing the likelihood of rejection and maintaining proper organ function. It is an important part of post-transplant treatment protocols under close medical supervision.
This combination contributes to achieving a delicate immune balance.
Prograf helps protect the patient from serious complications associated with organ transplant rejection. It also promotes health stability and improves the long-term success of the procedure. It is important to adhere to the prescribed doses and conduct periodic tests to monitor blood levels of the drug, ensuring its effectiveness and avoiding side effects as much as possible.